Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Atacicept Phase 2 Trial Yields Disappointing Results for MS
Guthy-Jackson Charitable Foundation
Stem Cells Stop the Train of MS Damage in Mice
Postdoctoral position in research on myelination
MS Research Roundup: July 9, 2014
Lower Risk of MS in People With HIV
Multiple Sklerose und Erbanlage
Abnormal Venous Outflow Dynamics May Not Be Implicated in MS
Fuel Injection
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.
MS Research Roundup: March 31, 2014
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Papers: 13 Jun 2014 - 20 Jun 2014
MS Trial Alert
Multiple Sclerosis Trust
Papers: 30 May 2014 - 6 Jun 2014
National Institutes of Health
Conducting Neural Dissonance
MS Genetics: The Outer Limits
FDA Approves Alemtuzumab for MS
MS Research Australia
Disseminated sclerosis in South Africa; its relationship to swayback disease and suggested treatment.
Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables.
Grant for Multiple Sclerosis Innovation (GMSI) 2016
MS Trial Alert: Researchers Nationwide Recruiting Children and Adolescents with MS for a Global Study of Gilenya
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »
